BMRN
Biomarin Pharmaceutical Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$58.51
-0.56 ▼ -0.95%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$59.51
+1.00 ▲ +1.71%
| Index | - | P/E | 32.84 | EPS (ttm) | 1.78 | Insider Own | 1.44% | Shs Outstand | 0.19B | Perf Week | -4.27% |
| Market Cap | 11.25B | Forward P/E | 11.04 | EPS next Y | 32.54% | Insider Trans | -1.73% | Shs Float | 0.19B | Perf Month | -2.98% |
| Enterprise Value | 10.34B | PEG | 0.2 | EPS next Q | 0.74 | Inst Own | 99.95% | Short Float | 4.36% | Perf Quarter | 8.96% |
| Income | 0.35B | P/S | 3.47 | EPS this Y | 122.11% | Inst Trans | 3.91% | Short Ratio | 3.32 | Perf Half Y | 4.65% |
| Sales | 3.24B | P/B | 1.85 | EPS next 5Y | 55.26% | ROA | 4.79% | Short Interest | 8.26M | Perf YTD | -1.55% |
| Book/sh | 31.65 | P/C | 7.21 | EPS past 3/5Y | 34.05% -16.79% | ROE | 5.94% | 52W High | -20.05% ($73.18) | Perf Year | -17.12% |
| Cash/sh | 8.11 | P/FCF | 15.52 | Sales past 3/5Y | 16.55% 11.97% | ROIC | 5.19% | 52W Low | 15.27% ($50.76) | Perf 3Y | -35% |
| Dividend Est. | - | EV/EBITDA | 11.53 | EPS Y/Y TTM | -18.8% | Gross Margin | 77.42% | Volatility(W/M) | 3.04% 3.91% | Perf 5Y | -23.79% |
| Dividend TTM | - | EV/Sales | 3.19 | Sales Y/Y TTM | 14.18% | Oper. Margin | 25.21% | ATR (14) | 2.1 | Perf 10Y | -33.71% |
| Dividend Ex-Date | - | Quick Ratio | 3.47 | EPS Q/Q | -137.57% | Profit Margin | 10.76% | RSI (14) | 42.84 | Recom | 1.58 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.18 | Sales Q/Q | 21.24% | SMA20 | -4.01% ($60.95) | Beta | 0.27 | Target Price | $88.91 |
| Payout | - | Debt/Eq | 0.11 | Earnings | 2000000 | SMA50 | -0.92% ($59.05) | Rel Volume | 0.48 | Prev Close | $59.07 |
| Employees | 3221 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | -241.68% 4.9% | SMA200 | 3.3% ($56.64) | Avg Volume(3M) | 2.48M | Price | $58.51 |
| IPO | 1999/7/23 | Option/Short | Yes/Yes | Trades | 15167 | Volume | 1,187,422 | Change | -0.95% |
뉴스 로딩 중...